Advanced Enzyme Technologies Reports Strong Financial Growth Amidst Liquidity Concerns in August 2025

Advanced Enzyme Technologies, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 2, 2025, indicate a notable shift in the company's evaluation, with a revision in its score reflecting a positive trajectory over the past three months.
The financial data reveals several strengths for Advanced Enzyme. The company achieved its highest operating cash flow at Rs 142.50 crore, demonstrating consistent growth in cash revenues from its business operations over the past three years. Additionally, net sales reached Rs 185.91 crore, marking a year-on-year growth of 20.31%, which underscores a favorable near-term sales trend. The operating profit, profit before tax, and profit after tax all reached their highest levels in the last five quarters, indicating robust performance across key profitability metrics. Furthermore, earnings per share also peaked at Rs 3.57, reflecting enhanced profitability for shareholders.

However, the financial results also highlight a challenge, as cash and cash equivalents were reported at their lowest level in the last six half-yearly periods, suggesting a decline in short-term liquidity.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.